Clinical Trials Browser

Surveys and Questionnaires × Other hematologic neoplasm × 90 days × Clear all

Bone Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Leukemia, Lymphoma, Melanoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Pyloric Stenosis, Hypertrophic

NCT01606033 2026-03-13

IPSY

Phase NA Completed

125 enrolled

Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT05371808 2026-03-11

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Recruiting

247 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05879133 2026-03-04

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

Phase NA Active not recruiting

30 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06897137 2026-02-24

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Not yet recruiting

3,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT05865301 2026-02-09

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

Recruiting

500 enrolled

Other hematologic neoplasm

Leukemia, Lymphoid

Clinical Trials

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

IPSY

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy